CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-14 | Smith Martin Alexander Executive Vice President | Grant or award · Restricted Stock Unit | +593 | 1,260 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion | +150 | 14,978.28 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion | +126 | 15,104.28 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion | +127 | 15,231.28 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion | +217 | 15,448.28 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion | +161 | 15,609.28 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Shares withheld for taxes | +235 | $505.53 | $119K | 15,374.28 |
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +7,009 | 7,009 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +197 | 197 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Grant or award · Restricted Stock Unit | +816 | 2,890 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion · Restricted Stock Unit | −150 | 2,740 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion · Restricted Stock Unit | −126 | 2,614 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion · Restricted Stock Unit | −127 | 2,487 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion · Restricted Stock Unit | −217 | 2,270 | ||
| 2022-02-14 | POLEWACZYK JAMES F Executive Vice President | Exercise or conversion · Restricted Stock Unit | −161 | 2,109 | ||
| 2022-02-14 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +459 | 26,785.64 | ||
| 2022-02-14 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +505 | 27,290.64 | ||
| 2022-02-14 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +435 | 27,725.64 | ||
| 2022-02-14 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +433 | 28,158.64 | ||
| 2022-02-14 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +253 | 28,411.64 |
Page 59 of 74 · 1,474 trades